Cargando…
PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428668/ http://dx.doi.org/10.1097/01.HS9.0000976124.84505.49 |
| _version_ | 1785090523984297984 |
|---|---|
| author | Song, Yuqin Wu, Helen Ji, Meng Jiang, Wenhan Dong, Cassie Zhu, Jun |
| author_facet | Song, Yuqin Wu, Helen Ji, Meng Jiang, Wenhan Dong, Cassie Zhu, Jun |
| author_sort | Song, Yuqin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428668 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104286682023-08-17 PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS Song, Yuqin Wu, Helen Ji, Meng Jiang, Wenhan Dong, Cassie Zhu, Jun Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428668/ http://dx.doi.org/10.1097/01.HS9.0000976124.84505.49 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Song, Yuqin Wu, Helen Ji, Meng Jiang, Wenhan Dong, Cassie Zhu, Jun PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_full | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_fullStr | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_full_unstemmed | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_short | PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS |
| title_sort | pb2351: trial in progress: a phase 2, multicentre study of brentuximab vedotin with chemotherapy in frontline treatment of chinese patients with cd30-positive peripheral t-cell lymphomas |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428668/ http://dx.doi.org/10.1097/01.HS9.0000976124.84505.49 |
| work_keys_str_mv | AT songyuqin pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT wuhelen pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT jimeng pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT jiangwenhan pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT dongcassie pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas AT zhujun pb2351trialinprogressaphase2multicentrestudyofbrentuximabvedotinwithchemotherapyinfrontlinetreatmentofchinesepatientswithcd30positiveperipheraltcelllymphomas |